The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology

Seminars in Hematology

Volumn 38, Issue 3 SUPPL. 8, 2001, Pages 3-8

  Witte, Owen ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; ENZYME ACTIVITY; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034876108     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(01)90111-8     Document Type: Review

References (30)

1. A minute chromosome in human chronic granulocytic leukemia
2. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
3. Lymphosarcoma: Virus-induced thymic-independent disease in mice
4. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells
5. A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product
6. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
7. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
8. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
9. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA
10. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
11. + translocation
12. An alteration of the human c-abl protein in K 562 leukemia cells unmasks associated tyrosine kinase activity
13. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene
14. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
15. In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the Philadelphia chromosome
16. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias
17. Acute leukaemia in bcr/abl transgenic mice
18. Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome
19. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
20. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice
21. Consequences of BCRABL expression within the hematopoietic stem cell in chronic myeloid leukemia
22. Hematopoietic commitment during embryonic stem cell differentiation in culture
23. Generation of lymphohematopoietic cells from embryonic stem cells in culture
24. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate
25. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
26. BCR/ABL inhibition by an escort/phosphatase fusion protein
27. Protein binding and signaling properties of RIN 1 suggest a unique effector function
28. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
29. A new ETV6/TEI-partner gene, ARG (ABL-related gene, or ABL2)-identified in an AML-M3 cell line with a -1: 12)(q25;p13) translocation
30. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases